首页> 外文期刊>Journal of Xi'an Medical University >The quantitative measurement of BCL-2, P53 protein and PCNA expression in breast carcinoma and their correlation with prognosis
【24h】

The quantitative measurement of BCL-2, P53 protein and PCNA expression in breast carcinoma and their correlation with prognosis

机译:乳腺癌中BCL-2,P53蛋白和PCNA表达的定量测定及其与预后的关系

获取原文
获取原文并翻译 | 示例
           

摘要

To study quantitative index of bcl-2, P53, proliferating cell nuclear antigen(PCNA), ER and PR in breast carcinoma and their correlation and their relationship with prognosis, the ex- Pression of bcl-2, P53 and PCNA were studied by immunohistochemical technique. The measurement Of ER and PR used enzyme linked affinity histochemical methods. The quantitative index was ana- Lyzed by image technique. All analyses were based on 60 breast carcinomas. The results were as fol- Lows: the more bcl-2 protein, the lower histological grade; the longer survival term and the higher Survival rate(P < 0.05).
机译:为了研究乳腺癌中bcl-2,P53,增殖细胞核抗原(PCNA),ER和PR的定量指标及其与预后的关系,通过免疫组化研究bcl-2,P53和PCNA的表达技术。 ER和PR的测定采用酶联亲和组织化学方法。定量指标通过图像技术进行分析。所有分析均基于60例乳腺癌。结果如下:bcl-2蛋白越多,组织学评分越低;生存期越长,生存率越高(P <0.05)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号